Primary IR Contact
For members of the press or investor community who wish to obtain more information about Vanda, please contact Jim Kelly Senior Vice President and Chief Financial Officer Vanda Pharmaceuticals, Inc. (202) 734-3428Email address protected from SPAM. Please enable JavaScript to contact me.